Results 81 to 90 of about 84,797 (237)

Plasma and Cerebrospinal Fluid Population Pharmacokinetics of Meropenem in Neurocritical Care Patients: a Prospective Two-Center Study

open access: yes, 2022
Morbidity and mortality related to ventriculitis in neurocritical care patients remain high. Antibiotic dose optimization may improve therapeutic outcomes. In this study, a population pharmacokinetic model of meropenem in infected critically ill patients
Joynt, Gavin M.   +23 more
core   +1 more source

Antimicrobial resistance patterns in bacterial isolates from mice and rats in Australian laboratory rodent facilities between 2015 and 2024

open access: yesAustralian Veterinary Journal, EarlyView.
Antimicrobial resistance (AMR) is a critical global challenge threatening human and animal health, food security and economic stability. Despite advances in understanding AMR trends of bacteria from humans, domestic animals, wildlife and environmental sources, there is limited understanding regarding AMR profiles of bacteria isolated from laboratory ...
RS Wilcox   +7 more
wiley   +1 more source

Carbapenems as Antidotes for the Management of Acute Valproic Acid Poisoning

open access: yesPharmaceuticals
Introduction: Valproic acid (VPA) is a broad-spectrum drug primarily used in the treatment of epilepsy and bipolar disorder. It is not an uncommon occurrence for VPA to cause intoxication.
Nataša Perković Vukčević   +6 more
doaj   +1 more source

Covariate determinants of effective dosing regimens for time-dependent beta-lactam antibiotics for critically ill patients

open access: yesBiomedical Papers, 2018
Aims: Critically ill patients undergoing aggressive fluid resuscitation and treated empirically with hydrosoluble time-dependent beta-lactam antibiotics are at risk for sub-therapeutic plasma concentrations. The aim of this study was to assess the impact
Milan Kaska   +5 more
doaj   +1 more source

Overview of meropenem-vaborbactam and newer antimicrobial agents for the treatment of carbapenem-resistant Enterobacteriaceae

open access: yes, 2018
Lindsay A Petty,1 Oryan Henig,1 Twisha S Patel,2 Jason M Pogue,3 Keith S Kaye1 1Department of Internal Medicine, Division of Infectious Diseases, University of Michigan Medical School, Ann Arbor, MI, USA; 2Department of Pharmacy Services, University of ...
Kaye KS   +4 more
core  

Tigecycline combination therapy for fulminant Clostridioides difficile infection: an Australian experience

open access: yesInternal Medicine Journal, EarlyView.
Abstract Background Recent European Society of Clinical Microbiology and Infection and Australasian Society of Infectious Diseases Clostridioides difficile infection (CDI) management guidelines endorse the addition of intravenous tigecycline in patients who are progressing to fulminant infection.
Emma Bishop   +5 more
wiley   +1 more source

A case of intrahepatic cholestasis developed under treatment with meropenem [PDF]

open access: yes, 2013
İntrahepatik kolestaz safranın bağırsağa kısmen ya da tamamen ulaşamamasıyla ortaya çıkan klinik tablo olup ilaçlar başta olmak üzere birçok neden etyolojide yer alabilmektedir. Meropenem uzun yıllardır klinik kullanımda olan geniş spektrumlu karbapenem
Tekin, Recep   +4 more
core   +1 more source

Urban ants as potential mechanical vectors of pathogenic and antibiotic‐resistant bacteria in a Brazilian hospital

open access: yesMedical and Veterinary Entomology, EarlyView.
Nine ant taxa were identified in a Brazilian hospital, with Tapinoma melanocephalum and Dorymyrmex brunneus being the most abundant. Eighty‐five percent of collected ants yielded detectable bacterial growth, including clinically relevant genera such as Acinetobacter, Pseudomonas, Escherichia coli and Pluralibacter.
Luana Biggi Souza   +10 more
wiley   +1 more source

Successful Treatment Using Apixaban in a Patient on Hemodialysis with Uremic Calciphylaxis

open access: yesClinical, Cosmetic and Investigational Dermatology, 2022
Moudi M Alasmari,1,2 Mona Y Alsheikh,3 Hend H Metwali2,4 1College of Medicine, King Saud Bin Abdulaziz University for Health Sciences, Jeddah, Saudi Arabia; 2King Abdullah International Medical Research Centre, Jeddah, Saudi Arabia; 3School of Pharmacy ...
Alasmari MM, Alsheikh MY, Metwali HH
doaj  

Meropenem Prevents Levofloxacin-Induced Resistance in Penicillin-Resistant Pneumococci and Acts Synergistically with Levofloxacin in Experimental Meningitis [PDF]

open access: yes, 2003
The aim of the present study was to investigate the potential synergy between meropenem and levofloxacin in vitro and in experimental meningitis and to determine the effect of meropenem on levofloxacin-induced resistance in vitro. Meropenem increased the
Entenza, J.   +22 more
core   +2 more sources

Home - About - Disclaimer - Privacy